368 related articles for article (PubMed ID: 29394589)
21. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
Mönig SP; Schröder W; Beckurts KT; Hölscher AH
Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
[TBL] [Abstract][Full Text] [Related]
22. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].
Nakajima T; Sato T; Kano K; Maezawa Y; Segami K; Fujikawa H; Ikeda K; Yamada T; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1240-1242. PubMed ID: 27760947
[TBL] [Abstract][Full Text] [Related]
23. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
24. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
25. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
[TBL] [Abstract][Full Text] [Related]
26. Reconstructive options for gastroesophageal junction adenocarcinoma after Roux-en-Y gastric bypass.
Kulaylat AN; Sahajwani S; Staveley-O'Carroll KF; Kaifi JT
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1296-8. PubMed ID: 23988286
[No Abstract] [Full Text] [Related]
27. A minimally invasive abdominal and left thoracic approach as a palliative treatment for adenocarcinoma of the esophagogastric junction with severe stenosis: A case report.
Takeuchi Y; Ebihara Y; Nakanishi Y; Asano T; Noji T; Kurashima Y; Murakami S; Nakamura T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Asian J Endosc Surg; 2020 Apr; 13(2):215-218. PubMed ID: 31240864
[TBL] [Abstract][Full Text] [Related]
28. [Gastric mixed adenoneuroendocrine carcinoma: a clinicopathological analysis of 36 cases].
Gao R; Chen XY; Jin L
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):767-771. PubMed ID: 31594040
[No Abstract] [Full Text] [Related]
29. Mixed adenoneuroendocrine carcinoma (MANEC) of the esophagogastric junction predominantly consisting of poorly differentiated neuroendocrine carcinoma.
Veits L; Lang-Schwarz C; Volkholz H; Falkeis C; Vieth M; Schulz H
Endoscopy; 2013; 45 Suppl 2 UCTN():E16-7. PubMed ID: 23468146
[No Abstract] [Full Text] [Related]
30. Minimally invasive abdominal and left thoracic approach for esophagogastric junction adenocarcinoma with esophageal diverticulum: A case report.
Takeuchi Y; Ebihara Y; Nakanishi Y; Asano T; Noji T; Kurashima Y; Murakami S; Nakamura T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Asian J Endosc Surg; 2019 Apr; 12(2):167-170. PubMed ID: 29888543
[TBL] [Abstract][Full Text] [Related]
31. Results of surgical therapy of adenocarcinomas of the esophagogastric junction according to a standardized surgical resection technique.
Meyer W; Popp M; Klinger L; Awad-Allah A; Gebhardt C
Dig Surg; 2002; 19(4):269-74; discussion 275. PubMed ID: 12207069
[TBL] [Abstract][Full Text] [Related]
32. [Optimal surgical approach for esophagogastric junction carcinoma].
Yamashita H; Seto Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
[TBL] [Abstract][Full Text] [Related]
33. Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M; Galizia G; Lieto E; De Vita F; Ciardiello F
World J Gastroenterol; 2015 Apr; 21(15):4427-31. PubMed ID: 25914451
[TBL] [Abstract][Full Text] [Related]
34. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.
Hölscher AH; Law S
Gastric Cancer; 2020 Jan; 23(1):3-9. PubMed ID: 31691875
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
[TBL] [Abstract][Full Text] [Related]
37. Challenges in the treatment of gastroesophageal junction cancer.
Liakakos T
World J Surg; 2011 Jun; 35(6):1409-10; author reply 1411. PubMed ID: 21301836
[No Abstract] [Full Text] [Related]
38. Collision tumor with three components at esophagogastric junction.
Pai SA; Kher N; Krishnamurthy S
Indian J Gastroenterol; 1997 Jul; 16(3):116. PubMed ID: 9248193
[TBL] [Abstract][Full Text] [Related]
39. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
[TBL] [Abstract][Full Text] [Related]
40. [A case showing a complete response by weekly paclitaxel associated with severe empyema and mediastinal abscess caused by reduction of a recurrent lung metastatic tumor originating from adenocarcinoma of the esophagogastric junction after primary operation].
Kimura A; Hiramatsu K; Sakuragawa T; Ito T; Otsuji H; Tsuchiya T; Hara T; Maeda T; Tanaka H; Machiki Y; Hosoya J; Kojima T; Kato K
Gan To Kagaku Ryoho; 2010 Feb; 37(2):303-5. PubMed ID: 20154490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
